Nov 22 (Reuters) - Britain's competition watchdog fined
U.S. firm Viatris ( VTRS ) 1.5 million pounds ($1.88 million) on
Friday for violating an order during its investigation into
Theramex's acquisition of European rights to two of Viatris's ( VTRS )
women's healthcare product ranges.
The Competition and Markets Authority (CMA) said Viatris ( VTRS )
breached regulations by failing to obtain its consent before
altering key staff and by not reporting the breach.
($1 = 0.7978 pounds)